{
    "Trade/Device Name(s)": [
        "Ascensia\u00ae ConTouR\u00ae Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Bayer HealthCare, Diabetes Care Division",
    "510(k) Number": "K062058",
    "Predicate Device Reference 510(k) Number(s)": [
        "K03657"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "September 11, 2006",
    "Summary Letter Received Date": "July 20, 2006",
    "Submission Date": "July 19, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Neonatal blood",
        "Capillary",
        "Venous",
        "Arterial"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Ascensia\u00ae ConTouR\u00ae Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose dehydrogenase enzymatic method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Monitoring System",
        "Analyzer",
        "Meter",
        "Strip",
        "Control Solution",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for Ascensia\u00ae ConTouR\u00ae Blood Glucose Monitoring System for measuring glucose in whole blood samples in home and healthcare settings",
    "Indications for Use Summary": "Measurement of glucose in whole blood for persons with diabetes and healthcare professionals in home and healthcare facility settings; indicated for capillary, venous, arterial, and neonatal blood samples",
    "fda_folder": "Clinical Chemistry"
}